| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.11.25 | Catheter Precision, Inc.: Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision's LockeT Device | 934 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 21.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.25 | Catheter Precision reports Q3 results | 1 | Seeking Alpha | ||
| 13.11.25 | Catheter Precision, Inc.: Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations | 680 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on the cardiac electrophysiology marketplace... ► Artikel lesen | |
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 13.11.25 | Catheter Precision, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.10.25 | Catheter Precision, Inc.: Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland | 208 | GlobeNewswire (Europe) | FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac procedures... ► Artikel lesen | |
| 15.10.25 | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09.25 | Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO | 173 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 10.09.25 | Catheter Precision, Inc.: Catheter Precision Announces Tender Win and First Purchase Order in Croatia | 1.124 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 04.09.25 | Catheter Precision, Inc.: Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
| 28.08.25 | Catheter Precision, Inc.: Catheter Precision Announces First Procedures in France as LockeT Expansion Continues | 1 | GlobeNewswire (USA) | ||
| 21.08.25 | Catheter Precision, Inc.: Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study | 2 | GlobeNewswire (USA) | ||
| 18.08.25 | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.08.25 | Catheter Precision's LockeT Wound Closure Device Approved In UK; Shares Soar Over 65% | 1 | RTTNews | ||
| 15.08.25 | Catheter Precision executes 1-for-19 reverse stock split | 2 | Seeking Alpha | ||
| 15.08.25 | Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split | 458 | GlobeNewswire (Europe) | FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for... ► Artikel lesen | |
| 15.08.25 | XFRA 4RM: AUSSETZUNG/SUSPENSION | 486 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCATHETER PR. NEW... ► Artikel lesen | |
| 15.08.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 15.08.2025 | 284 | Xetra Newsboard | The following instruments on XETRA do have their first trading 15.08.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 15.08.2025
Aktien
1 US4560361028 Industrial Bank of Korea... ► Artikel lesen | |
| 14.08.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 14.08.2025 | 632 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 14.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 14.08.2025.ISIN NameCA87168M1068 SYNEX... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,970 | +1,09 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,180 | -2,59 % | EILMELDUNG: Fresenius Medical Care-Aktie im freien Fall - Anleger fliehen aus dem Wert! | ||
| ECKERT & ZIEGLER | 15,790 | +0,45 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| BICO GROUP | 1,845 | +0,54 % | BICO Group AB: Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB | BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.
Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,080 | -3,64 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| RESMED | 210,50 | -1,27 % | RESMED INC: Statement of CDIs on issue - RMD | ||
| CARDINAL HEALTH | 179,95 | +0,87 % | Dividendenbekanntmachungen (02.01.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AIR PRODUCTS & CHEMICALS INC US0091581068 1,79 USD 1,5248 EUR ALICO INC US0162301040 0,05 USD 0,0425 EUR AMERICAN COASTAL INSURANCE... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,585 | +3,91 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer | SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet... ► Artikel lesen | |
| ZIMMER BIOMET | 79,66 | -1,75 % | Dividendenbekanntmachungen (30.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) APA GROUP AU000000APA1 0,275 AUD 0,1563 EUR AUTOHOME INC KYG066341028 0,3 USD 0,2548 EUR BRITISH AMERICAN TOBACCO PLC ADR US1104481072 0... ► Artikel lesen | |
| UNIDOC HEALTH | 0,089 | +0,57 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report | ||
| CO-DIAGNOSTICS | 5,620 | -2,26 % | XFRA C97: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCO-DIAGNOSTICS DL-... ► Artikel lesen | |
| CYTOSORBENTS | 0,614 | +4,42 % | Cytosorbents Corp: CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update | Third quarter 2025 revenue of $9.5 million, up 10% year-over-year
Amended credit agreement with Avenue Capital Group which strengthens our balance sheet... ► Artikel lesen | |
| VERU | 2,320 | -0,85 % | Veru Inc.: Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress | -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an... ► Artikel lesen | |
| CLARIANE | 3,878 | +4,53 % | Pflege braucht Vielfalt: Jetzt für den Korian Stiftungsaward 2026 bewerben | München (ots) - Die Korian Stiftung für Pflege und würdevolles Altern schreibt zum sechsten Mal ihren Award für Vielfalt und Respekt in der Pflege aus. Ausgezeichnet werden Einrichtungen, Pflegedienste... ► Artikel lesen |